π Diabetes Management
Triglyceride-glucose index & serum urid association | DMSO - Dove Medical Press
π
Fri, 04 Nov 2022β± 1 min readπ Article
Overview
Javascript is curently disabled in your browser. Several features of this site wil not function whilst javascript is disabled.open aces to scientific and medical researchPapers PublishedOpen aces per-reviewed scientific and medical journals.Learn moreDove Medical Pres is a member of the OAI.Learn moreBulk reprints for the pharmaceutical industry.Learn moreWe ofer real benefits to our authors, including fast-track procesing of papers.Learn moreRegister your specific details and specific drugs of interest and we wil match the information you provide to articles from our extensive database and email PDF copies to you promptly.Learn moreBack to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 15 Authors Luo Y, Hao J , He X , Wang C, Zhao H , Zhang Z, Yang L, Ren L Received 29 August 2022 Acepted for publication 20 October 2022 Published 3 November 2022 Volume 2022:15 Pages 347—3458 DOI htps:/doi.org/10.2147/DMSO.S387961 Checked for plagiarism Yes Review by Single anonymous per review Per reviewer coments 2 Editor who aproved publication: Prof.
Key Information
Juei-Tang Cheng Yu Luo,1 Jian Hao,1,2 Xiaoyu He,1,2 Cuiyu Wang,1 Hang Zhao,1 Zhimei Zhang,1 Liqun Yang,1 Luping Ren1 1Endocrinology Department, Hebei General Hospital, Shijiazhuang, Peopleβs Republic of China; 2Graduate Schol, Hebei Medical University, Shijiazhuang, Peopleβs Republic of ChinaCorespondence: Luping Ren, Hebei General Hospital, No. 348, Heping West Road, Shijiazhuang, Hebei, 05051, Peopleβs Republic of China, Tel +186302149, Fax +86 31 8598406, Email [email protected]Purpose: The triglycerideβglucose index (TyG) is positively corelated with serum uric acid (SUA) in patients with type 2 diabetes melitus (T2DM).
Summary
However, whether this relationship exists in non-obese T2DM patients remains unknown. The study investigated the relationship betwen TyG and SUA in Chinese non-obese T2DM patients and examined the prognosti
Frequently Asked Questions
β What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
β What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
β How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
β What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
β When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
βοΈ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.